Description

Latromotide is a synthetic peptide with antineoplastic activity. It consists of 10 amino acids corresponding to amino acid residues 66-75 of the human kinesin-like protein KIF20A. Latromotide has a sequence of H-Lys-Val-Tyr-Leu-Arg-Val-Arg-Pro Leu-Leu-OH[1].—–C60H105N17O12—-[1]S Kopp-Kubel, et al.International Nonproprietary Names (INN) for pharmaceutical substances. Bull World Health Organ. 195, 73, 3.–1049674-65-8–1256.58—-OC(C=C1)=CC=C1C[C@H](NC([C@H](C(C)C)NC([C@@H](N)CCCCN)=O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N2[C@@H](CCC2)C(N[C@@H](CC(C)C)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O–Cancer–10 mM in DMSO–Others—-Others–Peptides